ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,865.13
      -1.41%
      US Tech 100
      19,851.00
      -2.44%
      Dow Jones
      43,424.58
      -0.75%
      Brent Oil
      70.905
      -1.81%
      Bitcoin
      89,561.53
      2.54%
      Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ

      6. IN8bio Inc (INAB) Quote

      IN8bio Inc

      IN8bio Inc (INAB)

      NASDAQ
      0.33
      -0.006
      ( -1.79% )
      Updated: 13:04:23
      Delayed by 15 minutes

      Professional-Grade Tools, for Individual Investors.

      Premium

      Key stats and details

      Current Price
      0.33
      Bid
      0.33
      Ask
      0.345
      Volume
      410,202
      0.3111 Day's Range 0.3618
      0.217 52 Week Range 2.48
      Market Cap
      15.44M
      Previous Close
      0.336
      Open
      0.3361
      Last Trade
      405
      @
      0.33
      Last Trade Time
      13:04:28
      Financial Volume
      $ 133,993
      VWAP
      0.326651
      Average Volume (3m)
      1,160,778
      Shares Outstanding
      46,786,948
      Dividend Yield
      -
      PE Ratio
      -0.51
      Earnings Per Share (EPS)
      -0.64
      Revenue
      -
      Net Profit
      -30.01M

      About IN8bio Inc

      IN8bio Inc is a clinical-stage biotechnology company. It is focused on developing innovative therapies for the treatment of cancers, including solid tumors, by employing allogeneic, autologous and genetically modified gamma-delta T cells. IN8bio Inc is a clinical-stage biotechnology company. It is focused on developing innovative therapies for the treatment of cancers, including solid tumors, by employing allogeneic, autologous and genetically modified gamma-delta T cells.

      Sector
      Biological Pds,ex Diagnstics
      Industry
      Biological Pds,ex Diagnstics
      Website
      www.in8bio.com
      Headquarters
      Wilmington, Delaware, USA
      Founded
      -
      IN8bio Inc is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker INAB. The last closing price for IN8bio was $0.34. Over the last year, IN8bio shares have traded in a share price range of $ 0.217 to $ 2.48.

      IN8bio currently has 46,786,948 shares outstanding. The market capitalization of IN8bio is $15.72 million. IN8bio has a price to earnings ratio (PE ratio) of -0.51.

      Ask ADVFN Intelligence (AI)

      INAB Latest News

      More News

      Form EFFECT - Notice of Effectiveness

      November 13 2024
      Edgar (US Regulatory)

      Form 424B3 - Prospectus [Rule 424(b)(3)]

      November 12 2024
      Edgar (US Regulatory)

      Form 10-Q - Quarterly report [Sections 13 or 15(d)]

      November 12 2024
      Edgar (US Regulatory)

      IN8bio Reports Third Quarter 2024 Financial Results and Recent Corporate Highlights

      Reported 100% of Acute Myeloid Leukemia (AML) patients treated in INB-100 remain in complete remission (CR) at the 2024 European Hematology Association Congress and received FDA guidance for a...

      November 12 2024
      GlobeNewswire Inc.

      IN8bio Announces Plenary Oral Presentation at the 2024 Society for Neuro-Oncology (SNO) Annual Meeting

      Plenary Oral Presentation at SNO will provide latest clinical trial results from the previously enrolled INB-200 studies of autologous gamma-delta T cells for newly diagnosed glioblastoma (GBM...

      November 12 2024
      GlobeNewswire Inc.

      IN8bio Announces Upcoming Presentation at the 2024 American Society of Hematology (ASH) Annual Meeting

      NEW YORK, Nov. 05, 2024 (GLOBE NEWSWIRE) -- IN8bio, Inc. (Nasdaq: INAB), a clinical-stage biopharmaceutical company developing innovative gamma-delta T cell therapies, today announced an...

      November 05 2024
      GlobeNewswire Inc.

      Form S-3 - Registration statement under Securities Act of 1933

      November 04 2024
      Edgar (US Regulatory)

      Form D - Notice of Exempt Offering of Securities

      October 15 2024
      Edgar (US Regulatory)

      Form 4 - Statement of changes in beneficial ownership of securities

      October 11 2024
      Edgar (US Regulatory)

      Form 4 - Statement of changes in beneficial ownership of securities

      October 08 2024
      Edgar (US Regulatory)
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      1-0.015-4.347826086960.3450.370.30064249220.33319049CS
      40.143.47826086960.230.55660.2326849110.41023335CS
      12-0.228-40.86021505380.5580.58810.21711607780.39001973CS
      26-0.71-68.26923076921.041.740.2177409380.58023126CS
      52-0.6511-66.36428498620.98112.480.2176198280.89886378CS
      156-8.12-96.09467455628.458.890.2176669562.11882044CS
      260-9.67-96.71010.3190.2176113072.16860011CS

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      CEROCERo Therapeutics Holdings Inc
      $ 0.304
      (62.39%)
      		1.04B
      SPPLSIMPPLE Ltd
      $ 1.33
      (50.62%)
      		159.66M
      PTLEPTL Ltd
      $ 3.74
      (30.31%)
      		9.19M
      AGFYAgrify Corporation
      $ 17.23
      (26.60%)
      		353.59k
      CYCNCyclerion Therapeutics Inc
      $ 2.2316
      (26.08%)
      		3.9M
      TFFPTFF Pharmaceuticals Inc
      $ 0.3751
      (-76.56%)
      		7.6M
      EYENEyenovia Inc
      $ 0.1091
      (-67.92%)
      		36.71M
      VVPRVivoPower International PLC
      $ 0.8593
      (-36.35%)
      		1.95M
      ABPAbpro Holdings Inc
      $ 3.31
      (-33.67%)
      		37.71k
      QUBTQuantum Computing Inc
      $ 2.9881
      (-32.09%)
      		45.06M
      CEROCERo Therapeutics Holdings Inc
      $ 0.2986
      (59.51%)
      		1.04B
      ELABElevai Labs Inc
      $ 0.0226
      (-13.74%)
      		272.58M
      SPPLSIMPPLE Ltd
      $ 1.3401
      (51.77%)
      		159.68M
      NVDANVIDIA Corporation
      $ 141.445
      (-3.62%)
      		136M
      STISolidion Technology Inc
      $ 0.4282
      (22.34%)
      		112.73M

      INAB Discussion

      View Posts
      glenn1919 glenn1919 4 weeks ago
      INAB....................https://stockcharts.com/h-sc/ui?s=INAB&p=W&b=5&g=0&id=p86431144783
      👍️0
      Awl416 Awl416 1 month ago
      IN8bio Announces Pricing of $12.4 Million Private Placement
      👍️0
      BurgerKing82 BurgerKing82 2 months ago
      Hello
      👍️0
      glenn1919 glenn1919 2 months ago
      INAB...........................https://stockcharts.com/h-sc/ui?s=INAB&p=W&b=5&g=0&id=p86431144783
      👍️0
      TheFinalCD TheFinalCD 2 months ago
      $INAB 49% workforce reduction, focusing on INB-100https://t.co/C30I7yWH1v— Michelle Solly (@MSollender) September 4, 2024
      👍️0
      Monksdream Monksdream 3 months ago
      INAB new 52 week low
      👍️0
      glenn1919 glenn1919 5 months ago
      INAB....................................https://stockcharts.com/h-sc/ui?s=INAB&p=W&b=5&g=0&id=p86431144783
      👍️0
      glenn1919 glenn1919 6 months ago
      INAB.................................https://stockcharts.com/h-sc/ui?s=INAB
      &p=W&b=5&g=0&id=p86431144783
      👍️0
      Tyrus603 Tyrus603 7 months ago
      Talk about a delayed effect. But once more investors fully absorb the news... How big is the leukemia prescribed drug treatment market? Sky high run still possible.
      👍️0
      Laster Laster 7 months ago
      Sold my shares this morning that I bought last night for small loss.
      Volume not great. No PM movement (yet).
      Who knows. It may surprise and take off at 9:30 open.
      If it does, then congrats to y’all.
      👍️0
      Invest-in-America Invest-in-America 7 months ago
      INAB: Their Post-M news relates only PRE-Human findings, etc., at this point --- but, you simply publish a MAYBE-WE-GOT-A-POTENTIAL-CANCER-CURE type of PR and well, you know, a PRICE Moon landing tomorrow morning maybe??? (Holding circa 35% up in the Post-M, at this writing.)

      BOTTOM LINE??? GO-GO-GO-INAB!!!!
      👍️0
      glenn1919 glenn1919 8 months ago
      INAB.........................https://stockcharts.com/h-sc/ui?s=INAB&p=W&b=5&g=0&id=p86431144783
      👍️0
      Monksdream Monksdream 9 months ago
      INAB under $2
      👍️0
      murocman murocman 11 months ago
      Surprised how much this has tanked in light of stellar data?

      Murocman
      👍️0
      murocman murocman 11 months ago
      Outstanding data and financing in place to boot!

      Should move up!

      Murocman
      👍️0
      Awl416 Awl416 11 months ago
      IN8bio Announces Positive Clinical Update Demonstrating Continued Durable Complete Remission in 100% of Evaluable Patients in Phase 1 Trial of INB-100 in Leukemia
      👍️0
      Monksdream Monksdream 1 year ago
      INAB under $2
      👍️0
      Monksdream Monksdream 1 year ago
      INAB new 52 week low
      👍️0
      Monksdream Monksdream 1 year ago
      INAB new 52 week low
      👍️0
      The Night Stalker The Night Stalker 1 year ago
      https://stockcharts.com/h-sc/ui?s=inab&p=W&yr=0&mn=11&dy=25&id=p34307943936&a=1105106922&listNum=2
      👍️0
      The Night Stalker The Night Stalker 1 year ago
      like this
      👍️0
      The Night Stalker The Night Stalker 1 year ago
      like this
      👍️0
      The Night Stalker The Night Stalker 1 year ago
      looks good
      👍️0
      The Night Stalker The Night Stalker 1 year ago
      dip
      👍️0
      The Night Stalker The Night Stalker 1 year ago
      dip
      👍️0
      The Night Stalker The Night Stalker 1 year ago
      nice
      👍️0
      The Night Stalker The Night Stalker 1 year ago
      strong chart
      👍️0
      The Night Stalker The Night Stalker 1 year ago
      reaDY
      👍️0
      The Night Stalker The Night Stalker 1 year ago
      reaDY
      👍️0
      Mr Wick Mr Wick 1 year ago
      New INB 200 phase 1 data evaluating INB 200 patients will be available on Thursday 25 May. Also being presented at ASCO annual meeting on 02 June.
      Fingers crossed.
      👍️0
      The Night Stalker The Night Stalker 1 year ago
      nice
      👍️0
      MrMocha MrMocha 1 year ago
      I agree, INAB is going to do great things. A majority of their trials so far show great promise! I’m excited to see what their future holds..I can definitely see them being acquired in the not so distant future. Great find Mr Wick!
      👍️ 1
      Mr Wick Mr Wick 1 year ago
      New to ihub. Found in8bio a few weeks ago after the huge run recently. After researching I told a friend that " in8bio might be the best sleeper stock I have ever seen".
      Looking forward to a buyout.
      👍️ 1
      The Night Stalker The Night Stalker 1 year ago
      right on
      👍️0
      The Night Stalker The Night Stalker 2 years ago
      strong as hell
      👍️0
      Trons Trons 2 years ago
      Headed to $20 on cancer developments
      👍️0
      Jess070283 Jess070283 2 years ago
      Uh oh Shorts I’m trouble….
      👍️0
      trendzone trendzone 2 years ago
      Real DUMBASS move by the company this mornings news of offerings, but with the other big news out this week, it's probably a screaming buy on the reversal selloff, and sellers are acting like the fools that they are.
      👍️0
      Jess070283 Jess070283 2 years ago
      Loading this dip for the rip…
      👍️0
      Invest-in-America Invest-in-America 2 years ago
      INAB: It is CUTE!! (Hey, Boss, PBLA & INAB lookin' interesting; so too SAI, of course.)
      👍️0
      TheFinalCD TheFinalCD 2 years ago
      Update: IN8bio's INB-400, INB-410 Secure US FDA's Orphan Drug Designation -- Shares Surge Premarket
      HC Wainwright & Co. Reiterates Buy on IN8bio, Maintains $14 Price Target
      👍️0
      subslover subslover 2 years ago
      Love your scanner! :)
      👍️0
      2020Benzo 2020Benzo 2 years ago
      Did they just post same Orphan Drug news twice in a row it’s sane PR !
      👍️0
      TheFinalCD TheFinalCD 2 years ago
      sub $2
      👍️0
      surf1944 surf1944 2 years ago
      https://stockcharts.com/h-sc/ui?s=inab&p=D&yr=0&mn=6&dy=0&id=p38090673899

      https://www.barchart.com/stocks/quotes/inab/technical-chart?plot=CANDLE&volume=total&data=DO&density=ML&pricesOn=1&asPctChange=0&logscale=0&indicators=ACCUM;SMA(20);SMA(50);SMA(100);SMA(200);CHKMF(20)&sym=SYSX&grid=1&height=210&studyheight=100

      https://www.barchart.com/stocks/quotes/inab/opinion

      Back down to $1
      👍️0
      ringo1 ringo1 2 years ago
      Time to take some profits
      👍️0
      Hercules1 Hercules1 2 years ago
      It hit $3.95.

      $4 break is coming.


      $5 quite possible today.
      👍️0
      Hercules1 Hercules1 2 years ago
      Total beast.

      Next stop $4.

      And then $5.
      👍️0
      Awl416 Awl416 2 years ago
      Impressive day
      👍️0
      Jess070283 Jess070283 2 years ago
      What a beast!
      👍️0

      Your Recent History

      NASDAQ
      INAB
      IN8bio
      BOV
      XPID11
      FIRF XP IE FIDC
      Delayed Upgrade Clock